Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites
The objective of the current study was to compare the anticancer efficacy of doxorubicin-loaded cellulose based magnetic (Fe O ), zinc oxide (ZnO) nanoparticles on and free doxorubicin (DOX) on MCF-7 breast cancer cells. Novel pH-sensitive cellulose-graft poly acrylic acid based Fe O (Cellulose-g-PA...
Gespeichert in:
Veröffentlicht in: | Advanced pharmaceutical bulletin 2019-02, Vol.9 (1), p.122-131 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 131 |
---|---|
container_issue | 1 |
container_start_page | 122 |
container_title | Advanced pharmaceutical bulletin |
container_volume | 9 |
creator | Abbasian, Mojtaba Mahmoodzadeh, Farideh Khalili, Azra Salehi, Roya |
description | The objective of the current study was to compare the anticancer efficacy of doxorubicin-loaded cellulose based magnetic (Fe
O
), zinc oxide (ZnO) nanoparticles on and free doxorubicin (DOX) on MCF-7 breast cancer cells.
Novel pH-sensitive cellulose-graft poly acrylic acid based Fe
O
(Cellulose-g-PAAg- PAcMNPs) and ZnO (Cellulose-g-PAA-g-PAcZnO) nanocomposites were synthesized via polymerization of acrylic acid and modified 3-(trimethoxysilyl) propyl methacrylate onto the cellulosic backbone via reversible addition-fragmentation chain transfer (RAFT) method.
: Cellulose-g-PAA-g-PAcMNPs and Cellulose-g-PAA-g-PAcZnO nanocarriers with mean diameter of 15 and 38 nm were prepared successfully. DOX was loaded effectively to the ZnO and Fe
O
nanocarriers via complexing and electrostatic force with great encapsulation efficiency of 99.07% and 98.92%, respectively. DOX-loaded nanocarriers showed obvious pHdependent tumor specific drug release pattern. MTT assay results indicated that IC50 of the DOX loaded Cellulose-g-PAA-g-PAcZnO, DOX loaded Cellulose-g-PAA-g-PAcMNPs and free DOX after 48 hours treatment with MCF7 cell lines were about 24.03, 49.27 and 99.76 μg mL
, respectively. Therefore both DOX nanoformulations significantly increase antitumor ability compared to free DOX (
< 0.05). The results of MTT assay and DAPI staining revealed that DOX-loaded Cellulose-g-PAA-g-PAcZnO NPs show higher chemotherapy efficiency in MCF7 breast cancer cell line compare to the DOX-loaded Cellulose-g-PAA-g-PAcMNPs due to high interaction of ZnO with DOX.
The formation of the complexes between the DOX and ZnO nanoparticles at the chelating sites of the quinone and the phenolic oxygen molecules of DOX, lead to more sustained drug release and enhanced chemotherapy effectiveness by increasing the intracellular concentration of DOX. |
doi_str_mv | 10.15171/apb.2019.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6468221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2220144877</sourcerecordid><originalsourceid>FETCH-LOGICAL-p294t-d659f5e4be630d3fa0ad0f539319caa4e1aa763a64632655bd44cb281800ed993</originalsourceid><addsrcrecordid>eNpVkM1Lw0AQxRdRbKk9epUFz6k7-5GPi2CDWkEqiL0JYZJM2kiajdmk0P_eqFX0NANv-L15j7FzEDMwEMAVNulMCohmAswRG0tpwAuUCI8_dxl6JgxhxKbOlanQOpAhRHDKRgoEgPH9MXuNN7S13YZabPbcFnzeErqOx1hn1PKYqsrxlSvrNV_aHVW8WXjP5Bpbu3JHX3pfWUfeHB3lfIm1zey2sa7syJ2xkwIrR9PDnLDV3e1LvPAen-4f4ptHr5GR7rzcN1FhSKfkK5GrAgXmojAqUhBliJoAMfAV-tpX0jcmzbXO0iFLKATlUaQm7Pqb2_TplvKM6q7FKmnacovtPrFYJv-Vutwka7tLBmIoJQyAywOgte89uS55s31bDz8nQ40CtA6DYLi6-Gvzy_9pU30Ac1J4tQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2220144877</pqid></control><display><type>article</type><title>Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Abbasian, Mojtaba ; Mahmoodzadeh, Farideh ; Khalili, Azra ; Salehi, Roya</creator><creatorcontrib>Abbasian, Mojtaba ; Mahmoodzadeh, Farideh ; Khalili, Azra ; Salehi, Roya</creatorcontrib><description>The objective of the current study was to compare the anticancer efficacy of doxorubicin-loaded cellulose based magnetic (Fe
O
), zinc oxide (ZnO) nanoparticles on and free doxorubicin (DOX) on MCF-7 breast cancer cells.
Novel pH-sensitive cellulose-graft poly acrylic acid based Fe
O
(Cellulose-g-PAAg- PAcMNPs) and ZnO (Cellulose-g-PAA-g-PAcZnO) nanocomposites were synthesized via polymerization of acrylic acid and modified 3-(trimethoxysilyl) propyl methacrylate onto the cellulosic backbone via reversible addition-fragmentation chain transfer (RAFT) method.
: Cellulose-g-PAA-g-PAcMNPs and Cellulose-g-PAA-g-PAcZnO nanocarriers with mean diameter of 15 and 38 nm were prepared successfully. DOX was loaded effectively to the ZnO and Fe
O
nanocarriers via complexing and electrostatic force with great encapsulation efficiency of 99.07% and 98.92%, respectively. DOX-loaded nanocarriers showed obvious pHdependent tumor specific drug release pattern. MTT assay results indicated that IC50 of the DOX loaded Cellulose-g-PAA-g-PAcZnO, DOX loaded Cellulose-g-PAA-g-PAcMNPs and free DOX after 48 hours treatment with MCF7 cell lines were about 24.03, 49.27 and 99.76 μg mL
, respectively. Therefore both DOX nanoformulations significantly increase antitumor ability compared to free DOX (
< 0.05). The results of MTT assay and DAPI staining revealed that DOX-loaded Cellulose-g-PAA-g-PAcZnO NPs show higher chemotherapy efficiency in MCF7 breast cancer cell line compare to the DOX-loaded Cellulose-g-PAA-g-PAcMNPs due to high interaction of ZnO with DOX.
The formation of the complexes between the DOX and ZnO nanoparticles at the chelating sites of the quinone and the phenolic oxygen molecules of DOX, lead to more sustained drug release and enhanced chemotherapy effectiveness by increasing the intracellular concentration of DOX.</description><identifier>ISSN: 2228-5881</identifier><identifier>EISSN: 2251-7308</identifier><identifier>DOI: 10.15171/apb.2019.015</identifier><identifier>PMID: 31011566</identifier><language>eng</language><publisher>Iran: Tabriz University of Medical Sciences</publisher><subject>Biocompatibility ; Biopolymers ; Breast cancer ; Cancer therapies ; Cellulose ; Chemotherapy ; Drug delivery systems ; Drugs ; Efficiency ; Ethanol ; Nanocomposites ; Nanoparticles ; Polymerization ; Polymers ; Zinc oxides</subject><ispartof>Advanced pharmaceutical bulletin, 2019-02, Vol.9 (1), p.122-131</ispartof><rights>2019. This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 The Authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0434-2078 ; 0000-0001-9284-0055 ; 0000-0002-7354-3466</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468221/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468221/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31011566$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abbasian, Mojtaba</creatorcontrib><creatorcontrib>Mahmoodzadeh, Farideh</creatorcontrib><creatorcontrib>Khalili, Azra</creatorcontrib><creatorcontrib>Salehi, Roya</creatorcontrib><title>Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites</title><title>Advanced pharmaceutical bulletin</title><addtitle>Adv Pharm Bull</addtitle><description>The objective of the current study was to compare the anticancer efficacy of doxorubicin-loaded cellulose based magnetic (Fe
O
), zinc oxide (ZnO) nanoparticles on and free doxorubicin (DOX) on MCF-7 breast cancer cells.
Novel pH-sensitive cellulose-graft poly acrylic acid based Fe
O
(Cellulose-g-PAAg- PAcMNPs) and ZnO (Cellulose-g-PAA-g-PAcZnO) nanocomposites were synthesized via polymerization of acrylic acid and modified 3-(trimethoxysilyl) propyl methacrylate onto the cellulosic backbone via reversible addition-fragmentation chain transfer (RAFT) method.
: Cellulose-g-PAA-g-PAcMNPs and Cellulose-g-PAA-g-PAcZnO nanocarriers with mean diameter of 15 and 38 nm were prepared successfully. DOX was loaded effectively to the ZnO and Fe
O
nanocarriers via complexing and electrostatic force with great encapsulation efficiency of 99.07% and 98.92%, respectively. DOX-loaded nanocarriers showed obvious pHdependent tumor specific drug release pattern. MTT assay results indicated that IC50 of the DOX loaded Cellulose-g-PAA-g-PAcZnO, DOX loaded Cellulose-g-PAA-g-PAcMNPs and free DOX after 48 hours treatment with MCF7 cell lines were about 24.03, 49.27 and 99.76 μg mL
, respectively. Therefore both DOX nanoformulations significantly increase antitumor ability compared to free DOX (
< 0.05). The results of MTT assay and DAPI staining revealed that DOX-loaded Cellulose-g-PAA-g-PAcZnO NPs show higher chemotherapy efficiency in MCF7 breast cancer cell line compare to the DOX-loaded Cellulose-g-PAA-g-PAcMNPs due to high interaction of ZnO with DOX.
The formation of the complexes between the DOX and ZnO nanoparticles at the chelating sites of the quinone and the phenolic oxygen molecules of DOX, lead to more sustained drug release and enhanced chemotherapy effectiveness by increasing the intracellular concentration of DOX.</description><subject>Biocompatibility</subject><subject>Biopolymers</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cellulose</subject><subject>Chemotherapy</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Efficiency</subject><subject>Ethanol</subject><subject>Nanocomposites</subject><subject>Nanoparticles</subject><subject>Polymerization</subject><subject>Polymers</subject><subject>Zinc oxides</subject><issn>2228-5881</issn><issn>2251-7308</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkM1Lw0AQxRdRbKk9epUFz6k7-5GPi2CDWkEqiL0JYZJM2kiajdmk0P_eqFX0NANv-L15j7FzEDMwEMAVNulMCohmAswRG0tpwAuUCI8_dxl6JgxhxKbOlanQOpAhRHDKRgoEgPH9MXuNN7S13YZabPbcFnzeErqOx1hn1PKYqsrxlSvrNV_aHVW8WXjP5Bpbu3JHX3pfWUfeHB3lfIm1zey2sa7syJ2xkwIrR9PDnLDV3e1LvPAen-4f4ptHr5GR7rzcN1FhSKfkK5GrAgXmojAqUhBliJoAMfAV-tpX0jcmzbXO0iFLKATlUaQm7Pqb2_TplvKM6q7FKmnacovtPrFYJv-Vutwka7tLBmIoJQyAywOgte89uS55s31bDz8nQ40CtA6DYLi6-Gvzy_9pU30Ac1J4tQ</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Abbasian, Mojtaba</creator><creator>Mahmoodzadeh, Farideh</creator><creator>Khalili, Azra</creator><creator>Salehi, Roya</creator><general>Tabriz University of Medical Sciences</general><scope>NPM</scope><scope>8AO</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0434-2078</orcidid><orcidid>https://orcid.org/0000-0001-9284-0055</orcidid><orcidid>https://orcid.org/0000-0002-7354-3466</orcidid></search><sort><creationdate>20190201</creationdate><title>Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites</title><author>Abbasian, Mojtaba ; Mahmoodzadeh, Farideh ; Khalili, Azra ; Salehi, Roya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p294t-d659f5e4be630d3fa0ad0f539319caa4e1aa763a64632655bd44cb281800ed993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biocompatibility</topic><topic>Biopolymers</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cellulose</topic><topic>Chemotherapy</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Efficiency</topic><topic>Ethanol</topic><topic>Nanocomposites</topic><topic>Nanoparticles</topic><topic>Polymerization</topic><topic>Polymers</topic><topic>Zinc oxides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abbasian, Mojtaba</creatorcontrib><creatorcontrib>Mahmoodzadeh, Farideh</creatorcontrib><creatorcontrib>Khalili, Azra</creatorcontrib><creatorcontrib>Salehi, Roya</creatorcontrib><collection>PubMed</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advanced pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abbasian, Mojtaba</au><au>Mahmoodzadeh, Farideh</au><au>Khalili, Azra</au><au>Salehi, Roya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites</atitle><jtitle>Advanced pharmaceutical bulletin</jtitle><addtitle>Adv Pharm Bull</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>9</volume><issue>1</issue><spage>122</spage><epage>131</epage><pages>122-131</pages><issn>2228-5881</issn><eissn>2251-7308</eissn><abstract>The objective of the current study was to compare the anticancer efficacy of doxorubicin-loaded cellulose based magnetic (Fe
O
), zinc oxide (ZnO) nanoparticles on and free doxorubicin (DOX) on MCF-7 breast cancer cells.
Novel pH-sensitive cellulose-graft poly acrylic acid based Fe
O
(Cellulose-g-PAAg- PAcMNPs) and ZnO (Cellulose-g-PAA-g-PAcZnO) nanocomposites were synthesized via polymerization of acrylic acid and modified 3-(trimethoxysilyl) propyl methacrylate onto the cellulosic backbone via reversible addition-fragmentation chain transfer (RAFT) method.
: Cellulose-g-PAA-g-PAcMNPs and Cellulose-g-PAA-g-PAcZnO nanocarriers with mean diameter of 15 and 38 nm were prepared successfully. DOX was loaded effectively to the ZnO and Fe
O
nanocarriers via complexing and electrostatic force with great encapsulation efficiency of 99.07% and 98.92%, respectively. DOX-loaded nanocarriers showed obvious pHdependent tumor specific drug release pattern. MTT assay results indicated that IC50 of the DOX loaded Cellulose-g-PAA-g-PAcZnO, DOX loaded Cellulose-g-PAA-g-PAcMNPs and free DOX after 48 hours treatment with MCF7 cell lines were about 24.03, 49.27 and 99.76 μg mL
, respectively. Therefore both DOX nanoformulations significantly increase antitumor ability compared to free DOX (
< 0.05). The results of MTT assay and DAPI staining revealed that DOX-loaded Cellulose-g-PAA-g-PAcZnO NPs show higher chemotherapy efficiency in MCF7 breast cancer cell line compare to the DOX-loaded Cellulose-g-PAA-g-PAcMNPs due to high interaction of ZnO with DOX.
The formation of the complexes between the DOX and ZnO nanoparticles at the chelating sites of the quinone and the phenolic oxygen molecules of DOX, lead to more sustained drug release and enhanced chemotherapy effectiveness by increasing the intracellular concentration of DOX.</abstract><cop>Iran</cop><pub>Tabriz University of Medical Sciences</pub><pmid>31011566</pmid><doi>10.15171/apb.2019.015</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0434-2078</orcidid><orcidid>https://orcid.org/0000-0001-9284-0055</orcidid><orcidid>https://orcid.org/0000-0002-7354-3466</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2228-5881 |
ispartof | Advanced pharmaceutical bulletin, 2019-02, Vol.9 (1), p.122-131 |
issn | 2228-5881 2251-7308 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6468221 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Biocompatibility Biopolymers Breast cancer Cancer therapies Cellulose Chemotherapy Drug delivery systems Drugs Efficiency Ethanol Nanocomposites Nanoparticles Polymerization Polymers Zinc oxides |
title | Chemotherapy of Breast Cancer Cells Using Novel pH-Responsive Cellulose-Based Nanocomposites |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T13%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemotherapy%20of%20Breast%20Cancer%20Cells%20Using%20Novel%20pH-Responsive%20Cellulose-Based%20Nanocomposites&rft.jtitle=Advanced%20pharmaceutical%20bulletin&rft.au=Abbasian,%20Mojtaba&rft.date=2019-02-01&rft.volume=9&rft.issue=1&rft.spage=122&rft.epage=131&rft.pages=122-131&rft.issn=2228-5881&rft.eissn=2251-7308&rft_id=info:doi/10.15171/apb.2019.015&rft_dat=%3Cproquest_pubme%3E2220144877%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2220144877&rft_id=info:pmid/31011566&rfr_iscdi=true |